Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures pressure, temperature, force, or various other performance indicators in live tissue; and medical devices that remove subdermal implants. Lifecare ASA was founded in 2006 and is headquartered in Bergen, Norway.
Metrics to compare | LIFEA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLIFEAPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.6x | −4.8x | −0.5x | |
PEG Ratio | −0.18 | −0.06 | 0.00 | |
Price/Book | 3.2x | 8.6x | 2.6x | |
Price / LTM Sales | 68.0x | 6.0x | 3.2x | |
Upside (Analyst Target) | 88.1% | 32.4% | 38.8% | |
Fair Value Upside | Unlock | 4.8% | 5.4% | Unlock |